/
MDCX
$0.49+$0.03 (+6.51%)live
Held · Bookmarked
0 · 0
portfolios · users
Avg position size
—
of holders' portfolios
13F filers
0
institutions
Market cap
$25.9M
57M shares
52-week range
$0.25 – $3.69
7% from low
Sector
PHARMACEUTICAL PREPARATIONS
Exchange
NASDAQ
CS
Borrow rate
9.32%
Hard to borrow
Price (6 mo)
Loading chart…
Change$-2.16
Valuation
Financials
Loading chart…
Click rows below (any statement) to add/remove series. Selection stays as you switch tabs.
| 2021 | 2022 | 2023 | 2024 | 2025 | |
|---|---|---|---|---|---|
| Revenue | $0 | $0 | $0 | $0 | $0 |
| Cost of revenue | $0 | $0 | $0 | $0 | $0 |
| Gross profit | $0 | $0 | $0 | $0 | $0 |
| Gross margin | — | — | — | — | — |
| R&D | $1.2M | $646.4K | $193.6K | $3.5M | $7.7M |
| Operating income | −$1.4M | −$978.4K | −$4.7M | −$11.2M | −$18.4M |
| EBITDA | −$1.9M | −$1.2M | −$586.8K | −$11.2M | −$25.2M |
| Net income | −$2.1M | −$1.7M | −$5.3M | −$11.2M | −$25.4M |
| Net margin | — | — | — | — | — |
| EPS (diluted) | -0.26 | -0.21 | -1.06 | -1.16 | -1.96 |
Annual figures · source: Financial Modeling Prep
Analyst estimates (consensus)
| Year | Est. revenue | Est. EPS | EPS range | # Analysts |
|---|---|---|---|---|
| 2026 | $49440 | $-0.52 | $-0.59–$-0.44 | 1 |
| 2027 | $0 | $-0.39 | $-0.40–$-0.38 | 2 |
| 2028 | $31M | $-0.39 | $-0.39–$-0.39 | 1 |
| 2029 | $95M | $0.14 | $0.14–$0.14 | 1 |
Forward consensus · source: Financial Modeling Prep
DCF fair valuemodel estimate
Intrinsic value
$0.08
Price
$0.49
Implied downside
-83%
Peer comparison
Medicus Pharma Ltd. Common Stock
Medicus Pharma Ltd is a clinical-stage, life sciences, biotech company focused on investing in and accelerating clinical development programs of novel and potentially disruptive therapeutic assets. The company has one operating segment.
www.medicuspharma.com- Employees
- 16
- IPO / List date
- Nov 22, 2023
- HQ
- W. CONSHOHOCKEN, PA
Held by traders on TradeandTell
No one on the platform currently holds MDCX.
Super investors & insiders
Institutions holding (13F)
No tracked institution reports a position in MDCX as of their last filing.
Insider activity (SEC Form 4)
Recent trades on TradeandTell
No one on the platform has traded MDCX yet.
